FDA Clearance Tracker · P040044-S081
MynxGrip Vascular Closure Device
Last checked: Nov 20, 2026Latest source record: Jul 10, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Jul 10, 2018
Approved
Time to decision
55 days
Received May 16, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P040044-S081
- Device name
- MynxGrip Vascular Closure Device
- Applicant
- Cordis US Corporation
- Applicant location
- Miami Lakes, FL
- Received
- May 16, 2018
- Decided
- Jul 10, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P040044
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval to add Steri-Tek (Smart World LLC) located at 48225 Lakeview Boulevard, Fremont, California 94538, as a new E-beam sterilization site for the MynxGrip Vascular Closure Device (5F/6F/7F).
Source documents
Other decisions for Cordis US Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PRECISE PRO RX Transcarotid Stent SystemPMA supplement
P030047-S049 · Decided Apr 4, 2025 · 185 days after receipt · Panel Track
Device type: Stent, carotid (NIM) · Cardiology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.